UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 4,539	$ 468
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (benefit) for credit losses	(1,465)	5,297
Right-of-use amortization and cease use costs	80	91
Amortization of debt issuance costs	262	248
Deferred income taxes, net	1,265	229
Unrealized net loss on warrants	424	95
Net loss from exercise and cancellation of warrants	0	143
Loss from sale of assets	82	0
Loss on revaluation of finance receivables held for sale	3,727	0
Foreign currency transaction (gain) loss	(558)	783
Loss on marketable investments	105	231
Loan discount amortization and fee accretion	(1,487)	(837)
Interest paid-in-kind	(186)	(478)
Stock-based compensation	307	111
Depreciation and amortization expense	19	514
Changes in operating assets and liabilities:
Interest, accounts receivable and other receivables	(1,200)	(1,623)
Foreign currency forward contract	409	(870)
Other assets	980	(283)
Accounts payable, accrued expenses, and other non-current liabilities	(872)	(1,189)
Deferred income	1,849	1,500
Net cash provided by operating activities	8,280	4,430
Cash flows from investing activities:
Proceeds from sale of property and equipment	110	0
Sale of marketable investments	0	258
Investment in finance receivables	(10,000)	(446)
Repayment of finance receivables	32,684	9,362
Corporate debt securities principal payments	8	7
Purchases of property and equipment	(100)	0
Net cash provided by investing activities	22,702	9,181
Cash flows from financing activities:
Net payments on credit facility	(6,233)	(12,350)
Repurchases of common stock, including fees and expenses	(867)	(999)
Net cash used in financing activities	(7,100)	(13,349)
Net increase in cash and cash equivalents	23,882	262
Cash and cash equivalents at beginning of period	5,927	5,236
Cash and cash equivalents at end of period	29,809	5,498
Supplemental non-cash investing and financing activities:
Transfer of finance receivables and related interest receivable to held for sale	33,990	0
Cash paid for interest	775	173
Fair value of warrants received with investment in finance receivables	$ 253	$ 0